Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 21, 2005
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKKRudolf Waelchli, Birgit Bollbuck, Christian Bruns, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout miceGisbert Weckbecker, Christian Bruns, Klaus-Dieter Fischer, et al.
Journal of Medicinal Chemistry|October 17, 2012
An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluationDaniela Angst, Philipp Janser, Jean Quancard, et al.
Plos One|April 2, 2013
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitisAndreas Billich, Thomas Baumruker, Christian Beerli, et al.
The Journal of Biological Chemistry|April 23, 2002
The immune modulator FTY720 targets sphingosine 1-phosphate receptorsVolker Brinkmann, Michael D Davis, Christopher E Heise, et al.
Plos One|January 26, 2018
Metamaterial-based transmit and receive system for whole-body magnetic resonance imaging at ultra-high magnetic fieldsTim Herrmann, Thorsten Liebig, Johannes Mallow, et al.
RMD Open|February 23, 2025
Targeting the IL-17A pathway for therapy in early-stage tendinopathyNeal L Millar, Iain B McInnes, Frank Kolbinger, et al.
Journal of Medicinal Chemistry|April 2, 2004
Orally bioavailable competitive CCR5 antagonistsGebhard Thoma, François Nuninger, Marc Schaefer, et al.
European Journal of Endocrinology|April 9, 2005
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5Leo J Hofland, Joost van der Hoek, Richard Feelders, et al.
Pageof 4